Allstate saw an improvement in its IBD SmartSelect Composite Rating Monday, from 94 to 97.
The revised score means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Allstate has now climbed above a proper buy zone after breaking out from a 177.37 buy point in a cup without handle.
Discover The 3 Keys To Successful Stock Investing
The stock has an 82 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 82% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company posted a 383% rise in earnings for Q3. Sales growth climbed 15%, up from 12% in the prior quarter. That marks three consecutive reports with rising growth.
Allstate earns the No. 1 rank among its peers in the Insurance-Property/Casualty/Title industry group. AXIS Capital Holdings and Mercury General are also among the group's highest-rated stocks.
